Evaluating the Differential Effects of Valproic Acid on Wharton’s Jelly Mesenchymal Stem Cells

Homa Salami ¹, Seyed Javad Mowal ¹ , Rasoul Moukhah ², Zahra Hajebrahimi ³ , Seyed Abdolhakim Hosseini ⁴ , Houri Edalat ⁵ *

Cited by CrossRef: 5

1- Shokeir A, Awadalla A, Hamam E, Hussein A, Mahdi M, Abosteta A, Shahin M, Barakat N, El-Adl M, El-Sherbiny M, Eldesoqui M, AlMadani M, Ali S, El-Sherbini E, Khirallah S. Human Wharton's jelly-derived mesenchymal stromal stem cells preconditioned with valproic acid promote cell migration and reduce renal inflammation in ischemia/reperfusion injury by activating the AKT/P13K and SDF1/CXCR4 pathways. Archives of Biochemistry and Biophysics. 2024;755:109985 [Crossref]

2- Azarbarz N, Nejaddehbashi F, Khorsandi L, Bijan Nejad D, Sayyahi A. Autophagy enhances the differentiation of insulin-producing cells from Wharton’s jelly-derived mesenchymal stem cells. Tissue and Cell. 2024;88:102384 [Crossref]

3- Ghorbaninejad M, Khademi-Shirvan M, Hosseini S, Baghaban Eslaminejad M. Epidrugs: novel epigenetic regulators that open a new window for targeting osteoblast differentiation. Stem Cell Res Ther. 2020;11(1) [Crossref]

4- Hejazi S, Maleki M, Rasekh M. Study of the Cellular Senescence Process in Human Umbilical Cord Wharton's Jelly-derived Mesenchymal Stem Cells. 2023;13(4):361 [Crossref]

5- Işıldar B, Özkan S, Koyutürk M. Preconditioning of Human Umbilical Cord Mesenchymal Stem Cells with a Histone Deacetylase Inhibitor: Valproic Acid. Balkan Med J. 2024;:369 [Crossref]